General Atlantic, KKR and CVC are among global PE firms evaluating a minority stake in IndiaRF-backed Synthimed, which is seeking a $1 billion valuation ahead of a planned IPO.
Recent Posts
- Wall Street Should Worry More About AI Than Crypto, Says Changpeng Zhao As Anthropic’s Latest Announcement Hammers IBM Stock
- Michael Saylor Says Bitcoin’s Newness Is The ‘Strongest Argument’ Against It, But Notes It Took People 30 Years To Embrace Electricity
- Can Bharti Airtel’s ₹20,000 Cr NBFC Bet Become Its Next Big Growth Engine?
- Why Have Genus Power Shares Fallen by 22% Despite Strong Q3 Results? Check the Reason
- Jane Street faces claims of insider trading that sped up Terraform’s 2022 collapse